Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions

IF 5.6 2区 医学 Q1 HEMATOLOGY Critical reviews in oncology/hematology Pub Date : 2025-04-01 Epub Date: 2025-02-03 DOI:10.1016/j.critrevonc.2025.104651
Dingyi Fu , Haoquan Miao , Zhonglin Wang , Chuang Yang
{"title":"Gynecomastia and its potential progression to male breast cancer: Mechanisms, genetic factors, and hormonal interactions","authors":"Dingyi Fu ,&nbsp;Haoquan Miao ,&nbsp;Zhonglin Wang ,&nbsp;Chuang Yang","doi":"10.1016/j.critrevonc.2025.104651","DOIUrl":null,"url":null,"abstract":"<div><div>Gynecomastia is the most common breast condition in men, while male breast cancer remains relatively rare. This review explores the potential relationship between gynecomastia and male breast cancer, with a focus on the roles of hormonal imbalances, genetic factors, and molecular mechanisms in the progression of these conditions. While it remains controversial whether gynecomastia is a precancerous lesion for male breast cancer, this review summarizes the roles of estrogen and androgen receptors, the regulation of aromatase expression, and mutations in key genes such as BRCA1/2. These insights point to possible pathways by which gynecomastia could transition into male breast cancer. Additionally, hormones such as prolactin, insulin-like growth factor-1, and leptin may play significant roles in this progression. We provide an overview of the current understanding and identify key areas for further research, emphasizing the need for large-scale prospective studies to determine the causal relationship between gynecomastia and male breast cancer.</div></div>","PeriodicalId":11358,"journal":{"name":"Critical reviews in oncology/hematology","volume":"208 ","pages":"Article 104651"},"PeriodicalIF":5.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical reviews in oncology/hematology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1040842825000393","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gynecomastia is the most common breast condition in men, while male breast cancer remains relatively rare. This review explores the potential relationship between gynecomastia and male breast cancer, with a focus on the roles of hormonal imbalances, genetic factors, and molecular mechanisms in the progression of these conditions. While it remains controversial whether gynecomastia is a precancerous lesion for male breast cancer, this review summarizes the roles of estrogen and androgen receptors, the regulation of aromatase expression, and mutations in key genes such as BRCA1/2. These insights point to possible pathways by which gynecomastia could transition into male breast cancer. Additionally, hormones such as prolactin, insulin-like growth factor-1, and leptin may play significant roles in this progression. We provide an overview of the current understanding and identify key areas for further research, emphasizing the need for large-scale prospective studies to determine the causal relationship between gynecomastia and male breast cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
男性乳房发育症及其发展为男性乳腺癌的可能性:机制、遗传因素和激素的相互作用
男性乳房发育症是男性最常见的乳房疾病,而男性乳腺癌相对罕见。本文探讨了男性乳房发育症与男性乳腺癌之间的潜在关系,重点讨论了激素失衡、遗传因素和分子机制在这些疾病进展中的作用。尽管男性乳房发育是否为男性乳腺癌的癌前病变仍存在争议,但本文综述了雌激素和雄激素受体的作用、芳香化酶表达的调控以及BRCA1/2等关键基因的突变。这些见解指出了男性乳房发育可能转变为男性乳腺癌的途径。此外,催乳素、胰岛素样生长因子-1和瘦素等激素可能在这一过程中发挥重要作用。我们概述了目前的认识,并确定了进一步研究的关键领域,强调需要进行大规模的前瞻性研究来确定男性乳房发育症和男性乳腺癌之间的因果关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
11.00
自引率
3.20%
发文量
213
审稿时长
55 days
期刊介绍: Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.
期刊最新文献
Computer-aided diagnosis of papillary thyroid carcinoma based on deep learning technology Trispecific antibodies: From challenges to integration in cancer therapy Integrating venetoclax-based targeted and/or immune therapies for chronic lymphocytic leukemia Pathology in motion: Automation from specimen to report Rare but distinct: A systematic review of primary neuroendocrine tumors of the breast according to WHO 2019 guidelines
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1